A team of researchers has identified a plant-derived molecule that selectively extends the lifespan of female organisms by rewiring metabolic and nutrient-sensing pathways. The molecule, Corylin, is a flavonoid extracted from the traditional medicinal plant Psoralea corylifolia. When administered to mice starting at midlife under a standard, non-stressed dietary regimen, Corylin delayed multiple markers of physiological decline and extended survival exclusively in females.
The intervention operates via a dual-mechanism approach. Mechanistically, Corylin acts as a sex-blind brake on the mechanistic target of rapamycin (mTOR) pathway—a well-established driver of cellular aging and growth. It accomplishes this by directly binding to RAGA, a vital component of the nutrient-sensing machinery that feeds into mTOR complex 1. By dampening this pathway, Corylin effectively downregulates downstream signaling cascades that otherwise promote cellular senescence and systemic inflammation.
However, the lifespan extension properties of the compound diverge sharply by sex. While both male and female mice experienced substantial improvements in physical metrics—including muscle strength, coordination, and metabolic efficiency—only female mice demonstrated an extension in baseline longevity. The researchers traced this dimorphism to a secondary pathway: Corylin targets the estrogen receptor alpha (ESR1), which triggers the robust restoration of Sirtuin 3 (SIRT3), a critical mitochondrial enzyme that declines during aging. In females, this preserves mitochondrial structural integrity, lowers oxidative burden, and deacetylates key metabolic enzymes inside the citric acid cycle. In contrast, males lack the appropriate hormonal and receptor interplay required to activate this mitochondrial defense system, leaving their overall lifespan unchanged despite visible healthspan improvements.
Actionable Insights
-
Sex-Dependent Protocol Strategy: Therapeutic deployment of Corylin must prioritize biological sex. Females stand to gain both systemic healthspan and true lifespan extension, whereas males receive structural and functional healthspan benefits without direct survival extension.
-
Dose Translation: The effective murine dose was established at 450 mg/kg of standard rodent chow , which translates to an operational intake of roughly 50 mg/kg of body weight per day. Adjusted for human biology via body surface area scaling, this equates to an estimated human equivalent dose of approximately 4.05 mg/kg per day (roughly 280 mg daily for a 70 kg adult).
-
Contextual Necessity: Unlike previous interventions that require a high-fat or metabolic-stress baseline to demonstrate efficacy, Corylin delivers functional rejuvenation under standard dietary conditions. It does not operate as a caloric restriction mimetic via altered appetite, as food intake remained constant between groups.
-
Requirement for Chronic Exposure: Longevity benefits are not immediate. A single acute dose failed to alter mTOR or SIRT3 signaling cascade dynamics in target tissues, indicating that benefits require prolonged, steady-state clinical exposure.
-
Quantifiable Real-World Magnitude: The absolute magnitude of the primary benefit is a 11.9% increase in median survival for females. At advanced age (125 weeks), the intervention yielded a 33% higher absolute survival rate over age-matched controls.
Institutional Context & Impact Evaluation
1 Like
Corylin is not currently available on the commercial market as an over-the-counter retail consumer dietary supplement or standalone health capsule. However, it can be acquired through two specific commercial channels:
1. High-Purity Research Chemicals
For analytical and laboratory applications, highly purified Corylin extract (≥98% purity) is actively manufactured and sold as a reference standard or chemical reagent.
-
MedChemExpress (MCE): Offers Corylin as an orally active flavonoid in formats such as solid powder or pre-dissolved in DMSO starting at $60 for 5 mg up to $357 for 100 mg.
-
ChemFaces: Supplies high-purity natural Corylin powder extracted from the fruits of Psoralea corylifolia at a baseline rate of $90 for 20 mg.
2. Whole-Herb Extracts (Psoralea corylifolia)
While standalone isolated consumer supplements do not exist, the natural plant source containing Corylin—Psoralea corylifolia (commonly known as Bu Gu Zhi in Traditional Chinese Medicine or Babchi)—is widely available in consumer formats.
Corylin Quantification in Whole-Herb Extracts
-
The Reality of Raw Concentration: Corylin is a minor, trace flavonoid within Psoralea corylifolia (commonly known as Bu Gu Zhi or Babchi) seeds. While major constituents like the meroterpene bakuchiol (~11.71 mg/g) and the furocoumarin psoralen (~1.90 mg/g) dominate crude 70% ethanol extracts, Corylin content is exceptionally small, highly variable, and frequently unquantified in commercial batch profiling.
-
Knowledge Gap: Precise baseline data mapping the exact milligram-per-gram yield of Corylin across distinct extraction protocols (e.g., water reflux vs. ethanolic fractions) represents a severe gap in current literature. To establish a reliable metric for whole-herb products, standardized liquid chromatography-mass spectrometry (LC-MS) profiling across multiple commercial batches would be required. [Confidence: High]
Human Equivalent Dose (HED) Translation Deficit
-
Pure Compound Target: The murine longevity trial utilized an operational dose of 50 mg/kg/day of pure isolated Corylin. Scaled via allometric body surface area comparisons (multiplying by the standard mouse-to-human conversion factor of 0.081), the Human Equivalent Dose (HED) is 4.05 mg/kg/day. For a 70 kg individual, this requires ~283.5 mg of pure isolated Corylin daily.
-
The Scale-Up Dilemma: Assuming an optimistic trace yield where Corylin constitutes 0.1% of a high-potency crude extract (1 mg of Corylin per gram of extract), a human would need to ingest 283.5 grams of whole-herb extract daily to hit the target. Even at a highly implausible extract concentration of 1% pure Corylin, the daily intake would be 28.35 grams.
Severe Risks of Whole-Herb Dosing
Attempting to hit pure Corylin targets using crude Psoralea corylifolia preparations introduces catastrophic physiological risks due to the co-ingestion of massive quantities of toxic companion compounds:
-
Drug-Induced Liver Injury (DILI): Psoralea corylifolia is widely documented in clinical toxicology literature as a potent hepatotoxin. Megadosing whole-herb extracts to harvest trace flavonoids causes acute hepatocyte vacuolation, nuclear pyknosis, and steep elevations in liver transaminases (AST/ALT), driven primarily by the over-accumulation of coumarins and bakuchiol.
-
Phototoxicity and DNA Cross-Linking: The plant is exceptionally rich in linear furocoumarins (psoralen and isopsoralen). These compounds intercalate directly into cellular DNA. Upon minimal exposure to ultraviolet (UV) light, they trigger chemical photo-adduct formation and interstrand DNA cross-linking. This results in severe skin blistering, extreme photosensitivity, and an elevated long-term risk of skin malignancies.
-
Hormonal and Endocrine Disruption: Crude Psoralea corylifolia components possess broad, unselective estrogen receptor activities. Consuming tens of grams of crude material yields unpredictable systemic endocrine modifications, confounding the highly specific, targeted estrogen receptor alpha (ESR1) signaling cascade required for isolated Corylin’s longevity benefits.
Technical Verdict
Using crude Psoralea corylifolia extracts as a delivery mechanism for Corylin’s longevity benefits is highly impractical and clinically dangerous. The therapeutic window for the isolated compound cannot be safely replicated using the whole plant without triggering severe hepatotoxicity and phototoxic systemic poisoning. [Confidence: Elite]
1 Like
Short-Lived Control Mice: Evaluation Against Pabis et al. (2023) Criteria
According to the reference paper by Pabis, Barardo, et al., a mouse longevity study can only be interpreted with high confidence if the control group’s median lifespan is close to 900 days, or if the treated group’s maximum lifespan vastly exceeds 900 days. If control medians fall significantly short of this baseline, the cohorts are classified as short-lived.
-
Verdict: Yes, the controls in this study were short-lived. [Confidence: High]
- Both the female control median (~784–805 days) and the male control median (~840–868 days) drop significantly below the 900-day high-confidence standard.
- Even at 896 days (128 weeks), the female control group was nearly extinct, with an attrition rate of over 83%.
Methodological Implications
The authors themselves acknowledge this baseline compression in the discussion section, stating: “Notably, while the maximal lifespan observed in our cohort appears shorter than that reported in some studies in mice with a similar genetic background, the overall survival pattern and median lifespan are comparable.”
Per the Pabis et al. framework, utilizing control cohorts with compressed lifespans introduces a high risk of exaggerating the relative efficacy of a longevity intervention. When a control group is short-lived due to environmental or facility-specific stressors, a compound may extend lifespan simply by acting as a “remedy” or buffer against those specific lab stressors, rather than by slowing down the fundamental molecular velocity of intrinsic biological aging.
Consequently, because these controls did not hit the 900-day benchmark, the 11.9% lifespan extension observed in the female mice must be viewed with a higher degree of translational skepticism until independently replicated in a multi-center trial.